Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthRenu Medical is a regenerative medicine company focused on the development and distribution of advanced biologic solutions for wound care and surgical applications. The company offers a portfolio of human tissue allografts, including amniotic membranes, umbilical cord tissues, and liquid flowable grafts, marketed under brands such as RenuGraft and RenuFlow. These products are primarily utilized by clinicians to treat complex chronic wounds, such as diabetic foot ulcers and venous leg ulcers, by providing a natural scaffold for tissue regeneration. Beyond wound care, HealthRenu Medical serves the orthopedic and aesthetic markets, aiming to improve patient outcomes through minimally invasive regenerative therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HealthRenu Medical.